CD8A and neoplasm: Administration of anti-TGF-3 also enhanced both the systemic and tumor-infiltrating E7-specific CD8+ T cell response in mice treated with cisplatin and E7 long peptide, while administration of anti-TNF-a suppressed the generation of such immune responses (Fig. 3d, e).